Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Gut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...

Obesity-drug maker Metsera Inc.'s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market to rise in their stock-market debuts Friday ...

In today's health-conscious society, weight management has become a focal point for many individuals striving to achieve a balanced lifestyle. As obesity rates continue to rise globally, the quest for ...

When Andrew N. Ferguson took the helm last week at the FTC, his first act wasn't to announce new ways to crack down on corporate practices thought to be unfairly driving up consumer prices, it was to ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

BofA Securities, Piper Sandler, and Leerink Partners acted as lead bookrunners for the offering. Stifel acted as a bookrunner and Lake Street Capital Markets acted as co-manager for the offering.

Recent studies have shed light on these medications’ benefits and potential risks. Ozempic’s common side effects include nausea, diarrhea, constipation, and acid reflux, which are generally mild ...

Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.

Finding healthy protein sources on a budget doesn’t have to be difficult or tasteless. With the right choices, you can enjoy ...